Kevan M Shokat Selected Research

Kevan M Shokat Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 08/2002
9	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 04/2008
8	Glioma (Gliomas) 01/2017 - 12/2003
6	Breast Neoplasms (Breast Cancer) 12/2019 - 10/2008
5	Infections 01/2023 - 04/2013
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2007
4	COVID-19 02/2021 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
2	Heart Diseases (Heart Disease) 01/2022 - 01/2018
2	Starvation 09/2021 - 02/2003
2	Genomic Instability 01/2019 - 07/2013
2	Carcinoma (Carcinomatosis) 01/2019 - 01/2016
2	Parkinson Disease (Parkinson's Disease) 10/2017 - 08/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 12/2012
2	Triple Negative Breast Neoplasms 01/2017 - 01/2015
2	Hypersensitivity (Allergy) 01/2016 - 07/2012
2	Leukemia 08/2012 - 09/2008
2	Asthma (Bronchial Asthma) 06/2012 - 02/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2011 - 02/2011
2	Inflammation (Inflammations) 10/2008 - 08/2004
1	Adenocarcinoma 03/2024
1	Pathologic Processes 11/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 03/2021

Drug/Important Bio-Agent (IBA)

31	Phosphotransferases (Kinase)IBA 01/2020 - 08/2002
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2006
9	Sirolimus (Rapamycin)FDA Link 09/2021 - 09/2007
9	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018 - 04/2008
7	TOR Serine-Threonine KinasesIBA 01/2022 - 10/2008
7	Protein Isoforms (Isoforms)IBA 01/2018 - 04/2008
6	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2009
5	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2007
5	Adenosine Triphosphate (ATP)IBA 12/2012 - 03/2007
5	PI103IBA 11/2010 - 05/2006
4	Guanosine Triphosphate (GTP)IBA 03/2024 - 12/2010
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 08/2012
4	sapanisertibIBA 01/2020 - 02/2012
4	PP242IBA 01/2020 - 03/2010
3	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2011
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2020
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2007
3	Mechanistic Target of Rapamycin Complex 1IBA 09/2021 - 12/2010
3	EnzymesIBA 01/2020 - 05/2006
3	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2018 - 12/2003
3	Carbonyl Reductase (NADPH)IBA 10/2017 - 02/2011
3	TensinsIBA 01/2017 - 11/2010
3	Dasatinib (BMS 354825)FDA Link 01/2016 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 04/2006
3	LipidsIBA 08/2014 - 01/2007
2	AntigensIBA 01/2023 - 12/2022
2	AndrogensIBA 01/2022 - 10/2007
2	oxidized low density lipoproteinIBA 01/2022 - 01/2018
2	Drug CombinationsIBA 01/2022 - 01/2018
2	Monomeric GTP-Binding ProteinsIBA 01/2022 - 11/2013
2	CholesterolIBA 01/2022 - 09/2011
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 08/2002
2	MTOR InhibitorsIBA 01/2022 - 01/2018
2	RapaLink-1IBA 01/2022 - 01/2017
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 10/2009
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2019 - 11/2015
2	LigandsIBA 11/2019 - 10/2013
2	Aurora Kinase AIBA 01/2018 - 04/2016
2	Proprotein Convertase 9IBA 01/2018 - 01/2018
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 01/2018
2	calcium-dependent protein kinaseIBA 12/2017 - 04/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 02/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017 - 11/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 11/2015
2	Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 05/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2014 - 01/2009
2	epidermal growth factor receptor VIIIIBA 10/2013 - 05/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2012 - 09/2007
2	Tyrosine Kinase InhibitorsIBA 01/2010 - 01/2007
2	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 09/2008
1	sotorasibIBA 03/2024
1	Cysteine (L-Cysteine)FDA Link 03/2024
1	adagrasibIBA 03/2024
1	Aspartic Acid (Aspartate)FDA Link 03/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2023
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Insulin-Like PeptidesIBA 01/2023
1	Janus KinasesIBA 01/2023
1	Tumor Suppressor Protein p53IBA 01/2023
1	Insulin ReceptorIBA 01/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	AntibodiesIBA 12/2022
1	HaptensIBA 12/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	plitidepsin (aplidine)IBA 01/2021
1	Guanosine Diphosphate (GDP)IBA 10/2020

Therapy/Procedure

32	Therapeutics 01/2023 - 12/2003
3	Drug Therapy (Chemotherapy) 01/2016 - 04/2008
2	Radiotherapy 02/2015 - 04/2006